AstraZeneca makes $275m from Covid-19 vaccine sales
- Date: 30-Apr-2021
- Source: The National
- Sector:Healthcare
- Country:Middle East
AstraZeneca makes $275m from Covid-19 vaccine sales
AstraZeneca's made $275 million from Covid-19 vaccine sales, the pharmaceutical company said on Friday, after it reported robust revenue growth in the first quarter of the year.
It is the first time the British-Swedish firm, which is listed on the FTSE100, has offered details about the sales and distribution of its vaccine, which it developed with the University of Oxford and produces and supplies at cost.
Select Sector 
Select Country 
